Patents Assigned to CARNA HEALTH SUPPORT LTD.
  • Agent for treating retinal disease
    Patent number: 11382925
    Abstract: Agent for treating retinal disease such as aged-related maculopathy comprising sodium/glucose cotransporter2 inhibitor (SGLT2 inhibitor) as an active ingredient.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: July 12, 2022
    Assignee: CARNA HEALTH SUPPORT LTD.
    Inventors: Toyoshi Inoguchi, Mayumi Yamato
  • AGENT FOR TREATING RETINAL DISEASE
    Publication number: 20210154218
    Abstract: Agent for treating retinal disease such as aged-related maculopathy comprising sodium/glucose cotransporter2 inhibitor (SGLT2 inhibitor) as an active ingredient.
    Type: Application
    Filed: November 7, 2017
    Publication date: May 27, 2021
    Applicant: CARNA HEALTH SUPPORT LTD.
    Inventors: Toyoshi INOGUCHI, Mayumi YAMATO
  • Agent for treating retinopathy
    Patent number: 10821126
    Abstract: It is to provide an agent for treating and/or ameliorating retinopathy caused by glucose. It is an agent for treating retinopathy caused by glucose comprising sodium/glucose cotransporter2 inhibitor (SGLT2 inhibitor) as an active ingredient, and is used at a normal dosage amount, or at a lower dosage whereby no lowering in blood sugar is observed.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: November 3, 2020
    Assignee: CARNA HEALTH SUPPORT LTD.
    Inventors: Toyoshi Inoguchi, Yasutaka Maeda, Toshinobu Maki, Noriyuki Sonoda